Deutsches Museum

Dr. Kiana Aran's CRISPR-chip selected for national German exhibition on novel genetic research

Retrieved on: 
Wednesday, April 19, 2023

Cardea Bio's BPU variant, the CRISPR-chip - which made the cover of Nature Biomedical Engineering in June 2019 when it was first published – has been selected to be featured prominently in the exhibition.

Key Points: 
  • Cardea Bio's BPU variant, the CRISPR-chip - which made the cover of Nature Biomedical Engineering in June 2019 when it was first published – has been selected to be featured prominently in the exhibition.
  • Using the CRISPR-chip to democratize global access to powerful inventions like genotyping or genetic disease testing.
  • Watch the entire interview with Dr. Kiana Aran and Dr. Viktoria Krason here .
  • This is how we can democratize global access to powerful inventions like genotyping or genetic disease testing."

Vanguard Charitable Appoints New Board Member

Retrieved on: 
Wednesday, February 22, 2023

MALVERN, Pa., Feb. 22, 2023 /PRNewswire/ -- Vanguard Charitable, a leading nonprofit that sponsors donor-advised funds, announced today the appointment of its newest board member, Larry Dubinski, president and CEO of The Franklin Institute. Dubinski brings years of exceptional industry knowledge and executive leadership experience, which will support his role in furthering Vanguard Charitable's mission in philanthropy.

Key Points: 
  • MALVERN, Pa., Feb. 22, 2023 /PRNewswire/ -- Vanguard Charitable, a leading nonprofit that sponsors donor-advised funds, announced today the appointment of its newest board member, Larry Dubinski, president and CEO of The Franklin Institute.
  • "We're so pleased to welcome to our board a community leader and champion of the nonprofit organizations we work daily to support," said Vanguard Charitable President Rebecca Moffett.
  • We look forward to working alongside him to help guide the future of philanthropy at Vanguard Charitable."
  • "It is a great privilege to be welcomed to the Vanguard Charitable Board of Trustees," said Dubinski.

Pharma Trend Honors the Best Pharmaceutical Companies and the Most Innovative Products 2022

Retrieved on: 
Monday, October 10, 2022

The ranking Best pharmaceutical companies in Germany 2022 is set.

Key Points: 
  • The ranking Best pharmaceutical companies in Germany 2022 is set.
  • Janssen-Cilag, Novartis Pharma, Bayer Vital, Sanofi and Pfizer occupy spots one to five in the Pharma Trend Image & Innovation Award survey.
  • In addition, the four winners for the The Golden Tablet award were announced: BioNTech, InfectoPharm, Jenapharm and Janssen-Cilag.
  • It was part of the 23rd Pharma Trend Image & Innovation Award again this year under the patronage of the Bavarian Minister of Health Klaus Holetschek.

23rd Pharma Trend Image & Innovation Award

Retrieved on: 
Friday, September 23, 2022

On 13 September, the winners of the "Most Innovative Product" award in the category "Leap Innovations" were announced at the "Pharma Trend - Image & Innovation Award".

Key Points: 
  • On 13 September, the winners of the "Most Innovative Product" award in the category "Leap Innovations" were announced at the "Pharma Trend - Image & Innovation Award".
  • In addition, the winners of The Golden Tablet" were chosen and the Pharma Trend Ranking with the best pharmaceutical companies was published.
  • Since 2000, the Pharma Awards "The Golden Tablet" and "Most Innovative Product" have been presented for innovation and sustainability.
  • The basis for the award and the ranking is the Pharma Trend market research, which was conducted this year among 1,400 doctors, pharmacists and patients.

Pharma Trend Honors the Best Pharmaceutical Companies and the Most Innovative Products 2022

Retrieved on: 
Friday, September 16, 2022

The ranking Best pharmaceutical companies in Germany 2022 is set.

Key Points: 
  • The ranking Best pharmaceutical companies in Germany 2022 is set.
  • Janssen-Cilag, Novartis Pharma, Bayer Vital, Sanofi and Pfizer occupy spots one to five in the Pharma Trend Image & Innovation Award survey.
  • In addition, the four winners for the "The Golden Tablet" award were announced: BioNTech, InfectoPharm, Jenapharm and Janssen-Cilag.
  • It was part of the 23rd Pharma Trend Image & Innovation Award - again this year under the patronage of the Bavarian Minister of Health Klaus Holetschek.

Eurecon Verlag: Pharma Trend Awards Best Pharmaceutical Companies and the Most Innovative Products 2021

Retrieved on: 
Thursday, September 30, 2021

In addition to the company's research activity, a large product pipeline with many innovations is decisive for the award, as well as the quality of the products.

Key Points: 
  • In addition to the company's research activity, a large product pipeline with many innovations is decisive for the award, as well as the quality of the products.
  • The ranking "Best Pharmaceutical Companies Germany 2021" was also published: Roche Pharma, Lilly, Bristol-Myers Squibb, Novartis Pharma and Amgen occupy places one to five in the Pharma Trend Image & Innovation Award survey.
  • Thirteen other winners were able to enjoy the award "Most Innovative Product".
  • The app MyIUS from Jenapharm, which accompanies users of intrauterine systems, was chosen in the Digital Health Applications category.

Ethris Receives “Most Innovative Product Top 3” Award for COVID-19 Therapeutic Candidate at 22nd Pharma Trend Image & Innovation Award

Retrieved on: 
Wednesday, September 15, 2021

Ethris GmbH announced today that its lead COVID-19 therapeutic candidate, ETH47, has been awarded "Most Innovative Product Top 3" in the category of Leap Innovations at the Pharma Trend Image & Innovation Awards 2021.

Key Points: 
  • Ethris GmbH announced today that its lead COVID-19 therapeutic candidate, ETH47, has been awarded "Most Innovative Product Top 3" in the category of Leap Innovations at the Pharma Trend Image & Innovation Awards 2021.
  • ETH47 is a therapeutic candidate that harbors the mRNA blueprint for type III interferon.
  • The prize was presented to Dr. Carsten Rudolph, CEO of Ethris, at a ceremony on September 14, 2021 at the Deutches (German) Museum in Munich, Germany.
  • Ethris has paved a new path from genes to therapeutic proteins using its proprietary, non-immunogenic messenger RNA technology platform to discover, design and develop innovative therapies.